Prevalence of osteoporosis among thalassemia patients from Zafar Adult Thalassemia Clinic, Iran

Iranian Journal of Blood and Cancer

Volumn 6, Issue 3, 2014, Pages 143-148

  Hashemieh, M ^a   Azarkeivan, A ^b   Radfar, M ^a   Saneifard, H ^c   Hosseini Zijoud, S M ^d   Noghabaei, G ^a   Yaseri, M ^e  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bone mineral density; DEXA; Osteoporosis; Thalassemia

Indexed keywords

EID: 84925297432     PISSN: None     EISSN: 20084595     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Weatherall DJ, JB C. The thalassemia syndromes 4ed. Oxford: Malden, MA: Blackwell Science 2001.
2. Wonke B. Bone disease in beta-thalassaemia major. Br J Haematol. 1998;103(4): 897-901.
3. Voskaridou E, Terpos E. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br J Haematol. 2004;127(2):127-39.
4. Olivieri NF. The beta-thalassemias. N Engl J Med. 1999;341(2):99-09.
5. Calleja EM, Shen JY, Lesser M, Grady RW, New MI, Giardina PJ. Survival and morbidity in transfusiondependent thalassemic patients on subcutaneous desferrioxamine chelation. Nearly two decades of experience. Ann N Y Acad Sci. 1998;850:469-70.
6. Vichinsky EP. The morbidity of bone disease in thalassemia. Ann N Y Acad Sci. 1998;850:344-8.
7. Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, Yardumian A, et al. High prevalence of low bone mass in thalassaemia major. Br J Haematol. 1998;103(4):911-5.
8. Orvieto R, Leichter I, Rachmilewitz EA, Margulies JY. Bone density, mineral content, and cortical index in patients with thalassemia major and the correlation to their bone fractures, blood transfusions, and treatment with desferrioxamine. Calcified tissue international. 1992;50(5):397-9.
9. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organization technical report series. 1994;843:1-129.
10. Cefalu CA. Is bone mineral density predictive of fracture risk reduction? Current medical research and opinion. 2004;20(3):341-9.
11. Angelopoulos NG, Katounda E, Rombopoulos G, Goula A, Kaltzidou V, Kaltsas D, et al. Evaluation of bone mineral density of the lumbar spine in patients with beta-thalassemia major with dual-energy x-ray absorptiometry and quantitative computed tomography: a comparison study. J Pediatr Hematol Oncol. 2006;28(2):73-8.
12. Soliman AT, El Banna N, Abdel Fattah M, ElZalabani MM, Ansari BM. Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data. Metabolism. 1998 May;47(5):541-8.
13. Roth C, Pekrun A, Bartz M, Jarry H, Eber S, Lakomek M, et al. Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion. Eur J Pediatr. 1997;156(10):777-83.
14. Hajjar RR1, Kamel HK. Osteoporosis for the home care physician. Part 1: etiology and current diagnostic strategies. J Am Med Dir Assoc. 2004;5(3):192-6.
15. Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol. 2007;29(4):233-8.
16. Carmina E, Di Fede G, Napoli N, Renda G, Vitale G, Lo Pinto C, et al. Hypogonadism and hormone replacement therapy on bone mass of adult women with thalassemia major. Calcif Tissue Int. 2004;74(1):68-71.
17. Mahachoklertwattana P, Chuansumrit A, Sirisriro R, Choubtum L, Sriphrapradang A, Rajatanavin R. Bone mineral density, biochemical and hormonal profiles in suboptimally treated children and adolescents with beta-thalassaemia disease. Clin Endocrinol (Oxf). 2003;58(3):273-9.
18. Bielinski BK, Darbyshire P, Mathers L, Boivin CM, Shaw NJ. Bone density in the Asian thalassaemic population: a cross-sectional review. Acta Paediatr. 2001;90(11):1262-6.
19. Saffari F, Mahyar A, Jalilolgadr S. Endocrine and metabolic disorders in beta-thalassemiamajor patients. Caspian J Intern Med. 2012;3(3):466-72.
20. Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. Br J Haematol. 2000;111(3):902-7.
21. Anapliotou ML, Kastanias IT, Psara P, Evangelou EA, Liparaki M, Dimitriou P. The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches. Clin Endocrinol (Oxf). 1995;42(3):279-87.